Growth Metrics

Lexicon Pharmaceuticals (LXRX) Non-Current Debt: 2009-2012

Historic Non-Current Debt for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $22.3 million.

  • Lexicon Pharmaceuticals' Non-Current Debt fell 6.47% to $22.3 million in Q3 2012 from the same period last year, while for Sep 2012 it was $22.3 million, marking a year-over-year decrease of 6.47%. This contributed to the annual value of $23.5 million for FY2011, which is 14.24% down from last year.
  • As of Q3 2012, Lexicon Pharmaceuticals' Non-Current Debt stood at $22.3 million, which was down 1.74% from $22.7 million recorded in Q2 2012.
  • Over the past 5 years, Lexicon Pharmaceuticals' Non-Current Debt peaked at $43.9 million during Q1 2009, and registered a low of $22.3 million during Q3 2012.
  • In the last 3 years, Lexicon Pharmaceuticals' Non-Current Debt had a median value of $24.2 million in 2011 and averaged $25.2 million.
  • Data for Lexicon Pharmaceuticals' Non-Current Debt shows a maximum YoY crashed of 35.82% (in 2010) over the last 5 years.
  • Lexicon Pharmaceuticals' Non-Current Debt (Quarterly) stood at $28.5 million in 2009, then decreased by 3.99% to $27.3 million in 2010, then declined by 14.24% to $23.5 million in 2011, then decreased by 6.47% to $22.3 million in 2012.
  • Its Non-Current Debt was $22.3 million in Q3 2012, compared to $22.7 million in Q2 2012 and $23.1 million in Q1 2012.